menu search

IPHA / Innate Pharma SA (IPHA) Q1 2023 Earnings Call Transcript

Innate Pharma SA (IPHA) Q1 2023 Earnings Call Transcript
Innate Pharma SA (NASDAQ:IPHA ) Q1 2023 Earnings Conference Call May 10, 2023 8:00 AM ET Company Participants Henry Wheeler - VP, IR & Communication Mondher Mahjoubi - Chairman & CEO Joyson Karakunnel - EVP & Chief Medical Officer Yannis Morel - EVP, Product Portfolio Strategy & Business Development Frederic Lombard - SVP & CFO Conference Call Participants Ashiq Mubarack - Citigroup Daina Graybosch - SVB Securities Swayampakula Ramakanth - H.C. Wainwright & Co. Justine Telliez - Kepler Cheuvreux Jingming Chen - Evercore ISI Operator Thank you for joining the Innate Pharma Publication of Revenue for First Quarter 2023 Conference Call. Read More
Posted: May 13 2023, 22:17
Author Name: Seeking Alpha
Views: 010278

IPHA News  

Innate Pharma Announces Its Participation to Upcoming Investor Conferences

By Business Wire
October 27, 2023

Innate Pharma Announces Its Participation to Upcoming Investor Conferences

MARSEILLE, France--(BUSINESS WIRE)-- #ANKET--Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) today announced more_horizontal

Innate Pharma Announces Its Participation to Upcoming Investor Conferences and Conference Call for First Half 2023 Business Update

By Business Wire
August 29, 2023

Innate Pharma Announces Its Participation to Upcoming Investor Conferences and Conference Call for First Half 2023 Business Update

MARSEILLE, France--(BUSINESS WIRE)-- #ANKET--Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) today announced more_horizontal

Innate Pharma to Present Updated Interim Phase 2 Efficacy Results of Lacutamab in Mycosis Fungoides at the International Conference on Malignant Lymphoma

By Business Wire
June 12, 2023

Innate Pharma to Present Updated Interim Phase 2 Efficacy Results of Lacutamab in Mycosis Fungoides at the International Conference on Malignant Lymphoma

MARSEILLE, France--(BUSINESS WIRE)-- #ANKET--Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) today announced more_horizontal

Innate (IPHA) Gains as Blood Cancer Drug Gets Fast Track Tag

By Zacks Investment Research
June 9, 2023

Innate (IPHA) Gains as Blood Cancer Drug Gets Fast Track Tag

Innate (IPHA) and Sanofi's SAR'579 / IPH6101 get Fast Track Designation in the United States for the treatment of hematological malignancies. more_horizontal

Why Shares of Innate Pharma Jumped Thursday

By The Motley Fool
June 8, 2023

Why Shares of Innate Pharma Jumped Thursday

A therapy Innate Pharma and Sanofi are developing was granted Fast Track Designation by the FDA. Innate Pharma has enough cash to fund operations into more_horizontal

Innate Pharma to Participate in Upcoming Investor Conferences

By Business Wire
May 23, 2023

Innate Pharma to Participate in Upcoming Investor Conferences

MARSEILLE, France--(BUSINESS WIRE)-- #ANKET--Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) today announced more_horizontal

Innate Pharma to Present IPH6501 Preclinical Data at The EHA 2023 Congress

By Business Wire
May 15, 2023

Innate Pharma to Present IPH6501 Preclinical Data at The EHA 2023 Congress

MARSEILLE, France--(BUSINESS WIRE)-- #ANKET--Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) today announced more_horizontal

Innate Pharma SA (IPHA) Q1 2023 Earnings Call Transcript

By Seeking Alpha
May 13, 2023

Innate Pharma SA (IPHA) Q1 2023 Earnings Call Transcript

Innate Pharma SA (NASDAQ:IPHA ) Q1 2023 Earnings Conference Call May 10, 2023 8:00 AM ET Company Participants Henry Wheeler - VP, IR & Communication M more_horizontal


Search within

Pages Search Results: